147 related articles for article (PubMed ID: 183504)
1. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
Samaan NA; Smith JP; Rutledge FN; Schultz PN
Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
[TBL] [Abstract][Full Text] [Related]
2. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
4. The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.
Cerni C; Tatra G
Arch Gynecol; 1982; 231(2):159-65. PubMed ID: 6176191
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
6. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
Goldstein DP
Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
[No Abstract] [Full Text] [Related]
7. Beta-human chorionic gonadotrophin and carcino-embryonic antigen in the management of ovarian carcinoma.
Stone M; Bagshawe KD; Kardana A; Searle F; Dent J
Br J Obstet Gynaecol; 1977 May; 84(5):375-9. PubMed ID: 889730
[TBL] [Abstract][Full Text] [Related]
8. Ectopic production of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) by ovarian carcinoma.
Monteiro JC; Barker G; Ferguson KM; Wiltshaw E; Neville AM
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):173-8. PubMed ID: 6681763
[TBL] [Abstract][Full Text] [Related]
9. Serial determination of marker substances in ovarian cancer.
Stanhope CR; Smith JP; Britton JC; Crosley PK
Gynecol Oncol; 1979 Dec; 8(3):284-7. PubMed ID: 92437
[No Abstract] [Full Text] [Related]
10. Human chorionic gonadotropin and human placental lactogen in extragonadal tumors. An immunoperoxidase study of ten non-germ cell neoplasms.
Heyderman E; Chapman DV; Richardson TC; Calvert I; Rosen SW
Cancer; 1985 Dec; 56(11):2674-82. PubMed ID: 2413978
[TBL] [Abstract][Full Text] [Related]
11. Value of five tumor markers (AFP, CEA, hCG, hPL and SP1) in diagnosis and staging of testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Kamińska JA; Gadek A
Oncology; 1981; 38(4):222-9. PubMed ID: 6165945
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Valerio MG; Harris CC; Trump BF
Cancer Res; 1986 Nov; 46(11):5730-7. PubMed ID: 2428482
[TBL] [Abstract][Full Text] [Related]
13. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of tumor markers in epithelial ovarian cancer.
Casper S; van Nagell JR; Powell DF; Dubilier LD; Donaldson ES; Hanson MB; Pavlik EJ
Am J Obstet Gynecol; 1984 May; 149(2):154-8. PubMed ID: 6202143
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.
Dexeus F; Logothetis C; Hossan E; Samuels ML
J Urol; 1986 Aug; 136(2):403-7. PubMed ID: 2426474
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
17. Choriocarcinoma: expression of tumor- and trophoblast-associated antigens in patients with low chorionic gonadotropin excretion.
Seppälä M; Rutanen EM; Ranta T; Aho I; Nieminen U; Unnérus HA; Saksela E
Cancer; 1976 Nov; 38(5):2065-70. PubMed ID: 62610
[TBL] [Abstract][Full Text] [Related]
18. Trophoblastic proteins in ovarian carcinoma.
Crowther ME; Grudzinskas JG; Poulton TA; Gordon YB
Obstet Gynecol; 1979 Jan; 53(1):59-61. PubMed ID: 760019
[TBL] [Abstract][Full Text] [Related]
19. Interrelationships of human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta 1-glycoprotein throughout normal human gestation.
Braunstein GD; Rasor JL; Engvall E; Wade ME
Am J Obstet Gynecol; 1980 Dec; 138(8):1205-13. PubMed ID: 6969545
[TBL] [Abstract][Full Text] [Related]
20. Changes in placental lactogen, beta 1-chorionic gonadotropin, and unconjugated and total estriol levels in the late course of normal human pregnancy.
Furuhashi N; Tachibana Y; Kono H; Shinkawa O; Takahashi T; Suzuki M
Tohoku J Exp Med; 1984 May; 143(1):47-51. PubMed ID: 6205470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
